Eli Health Scores $12M To Make Hormone Monitoring As Easy as Checking Your Temp
The Montreal-based startup has raised $20 million to date as it prepares to launch its real-time, saliva-based hormone monitoring platform
Eli Health, a Montreal-based startup developing a non-invasive and instant hormone monitoring system, has raised $12 million in Series A funding to support its first product and expand its biomarker library.
The round was led by BDC Capital’s Thrive Venture Fund and brings Eli Health’s total funding to $20 million.
The company’s core offering, the Hormometer, delivers instant hormone readings from a saliva sample to an app in minutes, while also tracking trends and providing AI-powered recommendations for improvement. The platform is launching in beta with a focus on cortisol, a hormone tied to stress, energy and immune function. A waitlist is now open for progesterone, the next biomarker to join the platform.
Eli Health says its Hormometer – which earned recognition earlier this year at CES 2025, where it was named “Best of Innovation in Digital Health” – has secured FDA registration and is manufactured in-house. A private beta program is already underway ahead of Eli Health’s public launch later this year. Applications to join the beta program are currently open here.
“Hormones regulate nearly every major system in the body—governing stress response, sleep, cognitive and physical performance, metabolism, immune function and much more,” Eli Health co-founder and CEO Marina Pavlovic Rivas said. “But until now, this data has been largely invisible. It’s been too expensive, sporadic, and slow to offer the insight people need. We’ve created a real-time interface to the human body, where hormone tracking is as easy as checking your temperature and as quick as brushing your teeth. And now people will be able to use this data to guide daily decisions based on their body’s live feed.”
Subscription pricing starts at $8 per test for users on an annual plan, with other tiers available.
“Hormonal health is rapidly emerging as one of the most important frontiers in personal wellness,” BDC Thrive Venture Fund partner and Eli Health board member Mona Minhas said. “Eli Health recognized this shift early. Through years of focused execution, they’ve built the science, technological platform and manufacturing infrastructure to lead the category. We’ve been following Eli Health’s journey since the start, and it has been inspiring to see their bold vision become reality. Eli Health is a shining example of the kind of innovation and market leadership that aligns with the investment focus of the Thrive Venture Fund.”